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Previous experiments implicate cholinergic brainstem and spinal systems in the control
of locomotion. Our results demonstrate that the endogenous cholinergic propriospinal
system, acting via M2 and M3 muscarinic receptors, is capable of consistently producing
well-coordinated locomotor activity in the in vitro neonatal preparation, placing it in
a position to contribute to normal locomotion and to provide a basis for recovery of
locomotor capability in the absence of descending pathways. Tests of these suggestions,
however, reveal that the spinal cholinergic system plays little if any role in the induction
of locomotion, because MLR-evoked locomotion in decerebrate cats is not prevented
by cholinergic antagonists. Furthermore, it is not required for the development of
stepping movements after spinal cord injury, because cholinergic agonists do not
facilitate the appearance of locomotion after spinal cord injury, unlike the dramatic
locomotion-promoting effects of clonidine, a noradrenergic α-2 agonist. Furthermore,
cholinergic antagonists actually improve locomotor activity after spinal cord injury,
suggesting that plastic changes in the spinal cholinergic system interfere with locomotion
rather than facilitating it. Changes that have been observed in the cholinergic innervation of
motoneurons after spinal cord injury do not decrease motoneuron excitability, as expected.
Instead, the development of a “hyper-cholinergic” state after spinal cord injury appears
to enhance motoneuron output and suppress locomotion. A cholinergic suppression of
afferent input from the limb after spinal cord injury is also evident from our data, and this
may contribute to the ability of cholinergic antagonists to improve locomotion. Not only is
a role for the spinal cholinergic system in suppressing locomotion after SCI suggested by
our results, but an obligatory contribution of a brainstem cholinergic relay to reticulospinal
locomotor command systems is not confirmed by our experiments.
Keywords: spinal rhythm generation, cholinergic mechanisms, in vitro neonatal rat, decerebrate cat, chronic spinal
cat, chronic spinal rat
Abbreviations: 4-DAMP, 4-diphenylacetoxy-N-methylpiperidine methiodide; 5-
HT, 5-hydroxytryptamine, serotonin; ACh, acetylcholine; AChE, acetylcholine
esterase; AChR, acetylcholine receptor; aCSF, artificial cerebral spinal fluid; AF,
adductor femoris muscle; AHP, afterhyperpolarization; AIC, afferent input control;
BB, biceps brachii muscle; b.w., body weight; CIN, commissural interneurons;
CNF, nucleus cuneiformis; CNS, central nervous system; CPG, central pattern
generator; EDRO, edrophonium; EMG, electromyogram; ENG, electroneurogram;
GL, gastrocnemius lateralis muscle; GM, gastrocnemius medialis muscle; IaINs,
Ia inhibitory interneurons; I.D., internal diameter; IP, iliopsoas muscle; i.p.,
intraperitoneal; i.t., intrathecal; L2, L3, L4, L5, lumbar spinal cord segments; LRC,
locomotor rhythm control; M1, M2, M3, M4, muscarinic receptors; METHOC,
methoctramine; MLR, Mesencephalic Locomotor Region; MNs, motoneurons;
MT-3, muscarinic toxin-3; NEO, neostigmine; NMDA, N-Methyl-D-aspartate;
O.D., outside diameter; PPN, pedunculopontine nucleus; PT, posterior tibial nerve;
Pitx2, transcription factor; s.c., subcutaneously; SCI, spinal cord injury; SD, standard
deviation; Sol, soleus muscle; SP, superficial peroneal nerve; Srt, sartorius muscle;
St, semitendinosus muscle; T9, T10, T13, thoracic spinal cord segments; TA,
tibialis anterior muscle; TB, triceps brachii muscle; VAChT, vesicular acetylcholine
transporter; VL, vastus lateralis muscle; WAG rats, Wistar Albino Glaxo rats.
INTRODUCTION
Acetylcholine (ACh) is thought to be a transmitter in the brain-
stem system for initiation of locomotion (Garcia-Rill, 1986;
Jordan, 1998; Dubuc et al., 2008; Ryczko and Dubuc, 2013),
and is important at the spinal level because cholinergic pro-
priospinal cells may be involved in control of the Central Pattern
Generator (CPG) for locomotion (McCance and Phillis, 1968;
Huang et al., 2000; Jordan and Schmidt, 2002; Zagoraiou et al.,
2009; Miles and Sillar, 2011; Tillakaratne et al., 2014). In this
study we address three controversial issues: the importance of
the brainstem cholinergic system in the induction of locomotion
in adult animals, the capacity for the spinal cholinergic pro-
priospinal system to provide coordinated locomotor output, and
the importance of the spinal cholinergic propriospinal system in
the recovery of locomotor capability in the absence of descending
locomotor control.
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A role for brainstem cholinergic neurons in the production
of locomotion resulting from stimulation of the mesencephalic
locomotor region (MLR) in a number of species is now widely
accepted (Sholomenko et al., 1991; Dubuc et al., 2008; Smetana
et al., 2010; Ryczko and Dubuc, 2013), but the requirement
for cholinergic involvement in mammals remains controversial
(McCance et al., 1968a,b; Jordan, 1998; Takakusaki et al., 2003).
The MLR was originally described (Shik et al., 1966) as coex-
tensive with the nucleus cuneiformis (CNF), but subsequent
evidence has been obtained to implicate ACh, acting at mus-
carinic receptors, in the production of locomotor behavior in
mammals (Garcia-Rill and Skinner, 1987; Garcia-Rill et al., 1987),
and it has been suggested that the major output of the MLR to the
reticular formation is a cholinergic projection from the peduncu-
lopontine nucleus (PPN) (Garcia-Rill, 1986). More recent work
by Takakusaki et al. (2003, 2008) compared the effects of CNF and
PPN stimulation and confirmed the CNF as effective for inducing
locomotion, but the PPN stimuli induces muscle tone suppres-
sion. Garcia-Rill et al. (2011), while confirming that the PPN is
involved in the control of muscle tone, attempted to attribute the
effectiveness of CNF stimulation for production of locomotion to
the presence of cholinergic neurons within the effective sites in the
CNF. If this is the case, then cholinergic antagonists should impair
MLR-evoked locomotion whether the stimulus is localized to the
CNF or the PPN. We elected to determine if cholinergic antago-
nists could alter MLR-evoked locomotion in decerebrate cats. At
the same time, we tested the notion that cholinergic propriospinal
neurons contribute to the normal control of locomotion in adult
animals.
The mammalian spinal cord contains several types of cholin-
ergic neurons, including motoneurons, preganglionic autonomic
neurons, partition cells (lamina VII), at least two populations of
central canal neurons (lamina X) and small dorsal horn cells scat-
tered in lamina III-V (Barber et al., 1984; Houser et al., 1984;
Phelps et al., 1984; Borges and Iversen, 1986). These cells are likely
contributors to the effects of ACh in the spinal cord to the con-
trol of afferent input, including analgesia (Eisenach, 1999; Wess
et al., 2003; Umana et al., 2013). Cholinergic cells in laminae VII
and X are implicated in the control of locomotion (Huang et al.,
2000; Tillakaratne et al., 2014). Cholinergic excitation of neu-
rons involved in the control of locomotion has been demonstrated
(Dai et al., 2009; Dai and Jordan, 2010), and activity of choliner-
gic propriospinal cells during locomotion has been documented
(Webster and Jones, 1988; Carr et al., 1994, 1995; Huang et al.,
2000). Activity of premotoneuron cholinergic Pitx2+ V0c neu-
rons during locomotor episodes in vitro has been demonstrated
(Zagoraiou et al., 2009).
There is considerable evidence that ACh can induce rhyth-
mic activity in isolated spinal cord preparations, but usually the
rhythm is not locomotor-like: although there is a left-right alter-
nation, there is a synchronous activity in flexor and extensor
motoneurons on each side. However, there are examples in the
literature of well-coordinated locomotor-like activity produced
by cholinesterase inhibitors, which increase release of ACh from
intrinsic cholinergic neurons (Smith and Feldman, 1987; Smith
et al., 1988a; Cowley and Schmidt, 1994; Kiehn et al., 1996;
Anglister et al., 2008). In this study we showed that enhancing the
efficacy of the propriospinal cholinergic system in neonatal ani-
mals is sufficient for production of consistent well-coordinated
locomotor activity in vitro, and we determine the muscarinic
receptors involved in this effect. These findings formed the basis
for further investigation of the importance of spinal cholinergic
neurons in the production of locomotion in adult animals and in
animals with SCI.
Considerable attention has recently been drawn to the poten-
tial for the intraspinal cholinergic propriospinal system to influ-
ence functional recovery after loss of the descending command
pathways that normally trigger locomotion. Recovery of hindlimb
stepping has been related to sprouting of cholinergic fibers
after SCI (Jakeman et al., 1998). It has been demonstrated that
spinal motoneurons receive cholinergic C-terminals that excite
motoneurons by reducing the AHP, and the cholinergic neu-
rons that are the source of these terminals have been identified
(McCance and Phillis, 1968; Zagoraiou et al., 2009; Miles and
Sillar, 2011; Witts et al., 2014). Cholinergic commissural cells
have also been implicated in the control of locomotion and
suggested as a basis for cholinergic influences after SCI (Smith
et al., 1988a,b; Martin et al., 1989; Huang et al., 2000). Changes
in cholinergic propriospinal cells and inputs to motoneurons
after SCI have been documented (Kapitza et al., 2012; Skup
et al., 2012; Witts et al., 2014), and reduced numbers of cholin-
ergic C-terminals onto motoneurons has been suggested as a
basis for rapid exhaustion of the central drive required for
the performance of locomotor movements in patients with SCI
(Kapitza et al., 2012). Changes in the cholinergic control of
sensory inputs would also be expected if atrophy or other alter-
ations in cholinergic neurons involved in this process occur
after SCI. Given this background of plasticity in the choliner-
gic propriospinal system, and its putative involvement in loco-
motor activity after injury, we tested whether this system is
recruited during locomotor recovery in adult animals with SCI,
and determined the consequences of plasticity in this system
after SCI.
METHODS
Experimental procedures (neonatal rats and decerebrate cats)
were approved by the University of Manitoba Animal Care
Committee and conform to the standards of the Canadian
Council of Animal Care. The experiments on spinal rats were
carried out with the approval of the First Ethics Committee for
Animal Experimentation in Poland, according to the European
Union and the Polish Law on Animal Protection.
IN VITRO NEONATAL RAT PREPARATIONS
Dissection
Experiments were performed on 102 Sprague-Dawley rats aged
1–4 days. Following induction of anesthesia with Halothane®,
animals were quickly decerebrated and eviscerated then trans-
ferred to a 50ml chamber lined with Sylgard® containing arti-
ficial cerebral spinal fluid (aCSF): 128mM NaCl, 3mM KCl,
1μM MgSO4, 21mM NaHCO3, 1.5mM CaCl2.2HO3, 0.5mM
NaH2PO4.2H2O, and 30mM glucose, oxygenated with 95%
02/5% CO2. The entire spinal cord was exposed by removing
the vertebral bodies, then the isolated spinal cord was placed in
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the bath with the hindlimbs attached (n = 65). In some exper-
iments (n = 37) the hindlimbs were removed leaving only the
isolated spinal cord, to determine whether the feedback from the
attached moving limb influenced the results. In these cases, a
10ml chamber was used. Dorsal and ventral roots were cut from
cervical C1 to thoracic T12 and the surrounding tissue removed.
The dorsal/ventral roots in the lumbosacral region remained
intact in the hindlimb-attached preparations. When present, the
pelvis was stabilized with insect pins inserted into the underlying
Sylgard® to preventmovement from occurring during application
of neurochemicals. Bath temperature was maintained between
5◦ and 19◦C during surgery, while recordings were obtained
at room temperature (20◦–25◦C). The results obtained using
hindlimb—attached and isolated spinal cord preparations were
indistinguishable, and the data were pooled.
Recordings
Electroneurograms (ENGs) were obtained using plastic suction
electrodes filled with aCSF attached to lumbar roots L2 and L5
bilaterally, whether the hindlimbs were attached or not. Each ven-
tral root recording was band pass-filtered (30Hz to 3 kHz) and
stored on a PC for subsequent analysis using software developed
within our group. Details can be found at www.scrc.umanitoba.
ca/doc/. Briefly, raw waveform recordings from the ventral roots
were filtered at 1Hz then rectified. Sections of the rectified wave-
forms containing sustained locomotor activity were analyzed in
order to determine step cycle duration (onset of burst of activity
in one root to the onset of the next burst in the same root) and
frequency.
Circular statistics, as described previously (Kriellaars et al.,
1994; Kjaerulff and Kiehn, 1996; Cowley et al., 2005; Liu and
Jordan, 2005), were used to establish relationships between ven-
tral root recordings. Briefly, we determined the relationships
among locomotor-like bursts of activity recorded from pairs of
ventral roots in order to compare the mean phase values of
homolateral ventral roots to evaluate flexor (L2) vs. extensor
(L5) coordination, as well as bilateral ventral roots, to examine
right/left coordination. The angle (θ) of the mean vector repre-
sents the relationship between the reference onset and another
waveform. The vector points to the direction of the maximum
concentration of data points. The r-value, the correlation coef-
ficient, represents the concentration of data around that vector.
It is widely accepted that L2 ventral root activity consists largely
of flexor motoneuron activity and L5 ventral root activity cor-
responds to extensor motoneuron activity (Kjaerulff and Kiehn,
1996). Cycles were selected for analysis when a sustained pattern
of rhythmic activity was established.
Induction of rhythmic activity
Pharmacological substances were added by micropipette directly
to the bath solution. The aCSF was stirred by the air mixture
bubbling in the chamber. The AChE inhibitor edrophonium
(EDRO), mean dose 50μM, (25–100μM, 10mM stock solu-
tion) was added directly to the chamber to induce rhythmic
activity. A second AChE inhibitor, neostigmine (NEO) in con-
centration 25μM, was also used to confirm the effects of EDRO.
Antagonists were added to the bath only when a sustained pattern
of ventral root activity compatible with hindlimb stepping was
produced.
Antagonists
Both nicotinic and muscarinic antagonists were examined in
46 preparations with well-coordinated locomotion induced by
EDRO in order to determine the cholinergic receptors involved.
The antagonists chosen were tubocurarine, a nicotinic antago-
nist (1–15μM, n = 8), and the muscarinic antagonists atropine
(M1234 antagonist, 100 nM, n = 5), telenzepine (M1 antagonist,
500 nM–20μM, n = 12), methoctramine (METHOC; M2 antag-
onist, 1–50μM, n = 14), 4-diphenylacetoxy-N-methylpiperidine
methiodide (4-DAMP) (M3 antagonist, 3 nM–1μM, n = 12),
and muscarinic toxin-3 (MT-3) (M4 antagonist, 5–300 nM, n =
3). Statistical analysis of the effects of antagonists was carried out
using Student’s t-Test for Paired Samples. All drugs were obtained
from Sigma.
DECEREBRATE CAT PREPARATIONS
Fifteen adult cats were initially anesthetized with a mixture of
nitrous oxide and Halothane® and then intubated. The left com-
mon carotid was cannulated and blood pressure monitored. A
cannula was inserted into the femoral vein for the delivery of
fluids and drugs. Animals were given intravenous injections of
dexamethasone (4mg, Hexadrol phosphate, Organon) to reduce
brainstem swelling. The head of each animal was fixed in a stereo-
taxic frame with all four limbs free to step on the treadmill.
The hindquarters were suspended by a sling under the belly of
the cat. The animals were decerebrated at the precollicular-post-
mammillary level and the anesthesia discontinued. Following a
recovery period of at least 1 h, stepping on the moving treadmill
was induced by electrical stimulation (square wave pulse 0.5ms
duration, 10–30Hz, 50–200μA) applied in the MLR (Shik et al.,
1966) with monopolar steel electrodes. The electrical threshold
for the initiation of hindlimb locomotion was determined by
slowly increasing the strength of stimulation until locomotion
ensued. Changes in the threshold for electrically induced locomo-
tion were reported relative to the normal variability in threshold
measurements observed with repeated control trials.
Locomotion of the hindlimbs was normally monitored using
bilateral intramuscular electrodes for electromyographic (EMG)
recordings similar to those described by English (1984) or
English andWeeks (1989). Teflon-coated stainless-steel wires with
exposed wire tip of 1–2mm were implanted in various combi-
nations of the following muscles: GL, TA, St and VL muscles.
In three experiments, bilateral forelimb locomotion was also
monitored with similar electrodes implanted within BB and TB
muscles. The EMGs were amplified and captured using custom
software.
Locomotion at four different treadmill speeds (0.3, 0.4, 0.6,
0.8m/s) was assessed prior to and after separate intravenous
doses of the muscarinic antagonist atropine (1.2–2.4mg/kg)
and/or the classical ganglionic nicotinic antagonist mecamy-
lamine hydrochloride (3–9mg/kg). Mecamylamine was given
alone in 8 cats. The remaining 7 animals received both mecamy-
lamine and atropine (atropine administered first in 4 animals;
mecamylamine administered first in the remaining 3 animals).
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Mecamylamine was administered by small injections (1–3 doses
of 1.0ml) of 1.0–4.5mg/kg/ml (injection time of <1min). The
injections of mecamylamine were given over a period of up to
50min (Noga et al., 1987) to limit the fall in blood pressure which
may be seen after its administration. Atropine was also infused
gradually (over a 2–3min period) to limit the transient drop in
blood pressure which could also occur with its administration.
The choice of drugs and the range of doses used was based upon
the following information: (a) Renshaw cell phasic activity asso-
ciated with fictive locomotion is blocked by equal or lower doses
of mecamylamine (Noga et al., 1987); (b) Renshaw cell activation
produced by stretch of the Achilles tendon is blocked by equal
or lower doses of atropine (Ryall and Haas, 1975); (c) responses
of cells recorded from a variety of locations within the brain to
either iontophoretic application of acetylcholine or to electrical
stimulation of afferent pathways is blocked by intravenous appli-
cation of atropine at quantities similar to or less than that given
in the present study (Crawford and Curtis, 1966; McCance et al.,
1968b; Lake, 1973). It is clear from radiolabeled tracer studies that
atropine readily passes through the blood-brain barrier (Proakis
and Harris, 1978).
The following parameters were measured: step cycle length,
EMG burst duration, and the number of EMG bursts per mus-
cle per step cycle. A linear envelope signal was first obtained by
passing each rectified EMG signal through an 8 or 16Hz low pass
filter. All integrated EMG channels were digitized simultaneously
at 200Hz per channel. Intralimb coordination was determined by
examining the temporal relationship between EMG activity of the
flexor and extensor muscles from the same limb. Interlimb coor-
dination was qualitatively assessed (for presence of walk, trot, or
gallop) and only differences following the administration of the
antagonists compared to the pre-drug controls for each treadmill
speed are reported. The onset for each step cycle was determined
from the EMG channel with the sharpest burst onsets and most
consistent activity throughout the experiment. All step cycles in
each channel were then normalized, the EMG activity averaged
and the standard deviations computed. The area of the EMG sig-
nal (mean and standard deviation) between the onset and offset
of each burst (relative to the baseline) was calculated as a quan-
titative measure of muscle activity during each burst in the step
cycle. The average step cycle duration and burst duration (as a
percentage of the step cycle) was computed for each trial.
SPINAL CAT PREPARATIONS
Chronic experiments were performed in 2 spinalized cats for a
period of 90 days with several injections of drugs per week. Acute
experiments (n = 9) were performed in unanesthetized decer-
ebrate cats a few hours after a complete spinalization (n = 4)
or around 1 week after spinalization (n = 5). All procedures
were conducted according to the Guide for the Care and Use of
Experimental Animals (Canada), using protocols approved by the
Ethics Committee of Université de Montréal.
Implantation of chronic EMG electrodes
All surgical procedures were performed in aseptic conditions
and under general anesthesia. The cats received buprenorphine
(0.01mg/kg s.c.) 1 h before surgery. They were pre-medicated
with ketamine (10mg/kg), acepromazine maleate (AtravetTM,
0.1mg/kg), and glycopyrrolate (0.01mg/kg) injected intramus-
cularly and anesthetized by isoflurane 1–3% in 95% O2 main-
tained through an endotracheal tube. Lactate Ringer solution was
administrated during the surgery through an intravenous catheter
in the cephalic vein. The body temperature and heart rate were
monitored during the whole surgery. The animal was secured in
a stereotaxic frame. The EMG electrode implantation was as in
Belanger et al. (1996) and Bouyer et al. (2001). The implanted
muscles were the following: Srt, St, VL, GL, and TA. The intrathe-
cal implantation was as in Chau et al. (1998). A fentanyl (2.5mg,
25μg/h) transdermal patch was fixed to the skin for 10 days after
surgery. The postoperative care was as in previous publications
(Belanger et al., 1996; Chau et al., 1998).
Recording and analysis procedures
The EMG signal was differentially amplified (bandwidth 100Hz
to 3 kHz) and digitized at 2 kHz. The EMGs were synchronized
to the video images of the hindlimbs using a digital time code,
recorded on the computer and on the video. Reflective mark-
ers were placed on the skin overlying the iliac crest, the femoral
head, the knee joint, the lateral malleolus, the metatarsopha-
langeal joint and the tip of the fourth toe. Video images of the
locomotormovement (left side) were captured by a digital camera
and recorded on a videocassette recorder at 30 frames/s.
The bursts of activity of all EMGs were rectified and integrated
to quantify their amplitude. Their onset and offset were identified
automatically by homemade software and corrected manually by
the experimenter in order to determine temporal parameters of
each cycle. The video images were digitized and the x-y coordi-
nates of different joint markers were obtained at the frequency of
60 fields/s by de-interlacing each video frame. These coordinates
were used to calculate angular joint movements and could be dis-
played as continuous angular displacements or stick diagrams of
one step cycle (see for instance Figure 6). The step length was cal-
culated as the distance between two consecutive contacts of the
same foot. The time interval between the onset and the offset of
each muscle was measured and synchronized to the onset of the
St EMG activity.
Spinalization and drug administration
Spinal cord transection was performed in aseptic conditions
and under general anesthesia following a protocol established in
Belanger et al. (1996) and Bouyer et al. (2001). Drug adminis-
tration was made either via a cannula inserted at T13 with the
tip at L4 (Chau et al., 1998) or in a bath over L3–L4 (Marcoux
and Rossignol, 2000). For intrathecal injections, concentrations
of stock solutions of drugs (atropine, 4-DAMP, dihydro-β-
erythroidine, EDRO) were adjusted so that the desired total dose
could be injected in a single 100μl bolus unless otherwise indi-
cated. The procedure was first to empty the cannula which had
a dead space of 100μl and then introduce the 100μl of the drug
and fill in the dead space again with saline.
Cutaneous reflex testing
In acute and 1 week spinal cats, cutaneous reflexes were tested
by stimulating cutaneous nerves through cuff electrodes inserted
Frontiers in Neural Circuits www.frontiersin.org November 2014 | Volume 8 | Article 132 | 4
Jordan et al. Cholinergic control of locomotion
around the Superficial Peroneal (SP) and Posterior Tibial (PT)
nerves on both sides and recording EMG responses through per-
cutaneously inserted electrodes in St, TA, GL, and Srt muscles.
Reflex responses were evaluated starting 5–10min up to 2 h after
the injection of drugs. The stimulating cuffs were stable and
allowed tests of threshold several times during the experiment.
SPINAL RAT PREPARATION
Spinal cord transection
The experiments were performed on 3-month-old WAG female
rats in which, under Isofluorane anesthesia (2% and Butomidor,
0.05mg/kg b.w.) and sterile conditions the spinal cord was com-
pletely transected at a low thoracic level (T9/10). To prevent the
possibility of axonal regrowth through the cavity of the lesion,
2–3mm of spinal cord tissue was aspirated using a glass pipette
as described previously (Sławin´ska et al., 2012). Then the mus-
cles and fascia overlying the paravertebral muscles were closed in
layers using sterile sutures, and the skin was closed with stainless-
steel surgical clips. After surgery, the animals received a non-
steroidal anti-inflammatory and analgesic treatment (Tolfedine
4mg/kg). During the following 7–10 days, the animals received
antibiotics (Gentamicin 2mg/kg and Baytril 5mg/kg) and the
bladder was emptied manually twice a day until the voiding reflex
was re-established.
Intrathecal cannula implantation
An intrathecal cannula was implanted such that the tip was tar-
geted to the level of L3/L4 root entrance to the spinal cord. The
procedure for intrathecal cannula implantation was similar to
that used previously (Majczyn´ski et al., 2005, 2006), except in this
case the cannula was inserted from the caudal end of the verte-
bral canal. The implantation was performed in aseptic conditions
under equithesin anesthesia (i.p. 0.35ml/100 g b.w.). A silastic
cannula (0.012 in I.D. × 0.025 in O.D.) was inserted into the sub-
arachnoid space through a small openingmade at the L3 vertebral
level and was pushed rostrally. The cannula was fixed by sewing it
to the L4 spinous process and stabilized by suturing the overlying
back muscles in place. The other end of the cannula was guided
under the skin to reach the skull and connected to a custom-made
adaptor cemented to the bone. After surgery, the animals received
a non-steroidal anti-inflammatory and analgesic treatment and
antibiotics. Two to five days after surgery the patency and correct
placement of the cannula was verified by injection of 15μl of 2%
lidocaine followed by 15μl of saline (0.9%). Drugs were injected
as a bolus of 20μl of drug diluted with sterile saline and followed
by a bolus of about 15μl of sterile saline to wash the drug from
the cannula. Drug injections were separated by an interval of at
least 72 h. A similar volume of sterile 0.9% saline was used as a
control injection.
Implantation of EMG recording electrodes
Ten weeks after spinal cord transection, bipolar EMG recording
electrodes were implanted in the Sol and TA muscles of both
hindlimbs as previously described (Sławin´ska et al., 2000, 2012,
2013). The electrodes were made of Teflon-coated stainless-steel
wire (0.24mm in diameter; AS633, Cooner Wire, Chastworth).
The tips of the electrodes with 1–1.5mm of the insulation
removed were pulled through a cutaneous incision at the back
of animal, and each of the hook electrodes was inserted into
the appropriate muscle, where it was secured by a suture. The
distance between the tips of electrodes was approximately 1–
2mm. The ground electrode was placed under the skin on the
back of the animal at some distance from the hindlimb mus-
cles. The connector with the wires fixed to it and covered with
dental cement and silicone was secured to the back of the
animal.
Locomotor function investigation
The hindlimb locomotor movements of spinal rats were inves-
tigated on a treadmill where the animals were kept with their
forelimbs on a platform above the treadmill and their hindlimbs
were touching the moving belt. Stimulation of the tail was used
to elicit locomotor-like hindlimb movements and then pharma-
cological agents (carbachol, and 10–15min later atropine) were
applied intrathecally (both 20μl, 1mM). Simultaneously with
EMG recordings a digital video camera was used to record the
hindlimb movements. The animals were tested before and at
various times after the drug application. EMG recordings were
used to determine the quality of any locomotor activity induced
by the tail pinching as described before (Sławin´ska et al., 2012,
2014).
RESULTS
IN VITRO EXPERIMENTS IN NEONATAL RATS
The intrinsic cholinergic propriospinal system is a potential sub-
strate for locomotor recovery after SCI (Jordan and Schmidt,
2002), because other transmitter systems capable of inducing
locomotion (e.g., noradrenergic, serotonergic, and dopamin-
ergic) arise from brain cells forming descending pathways
(Rossignol et al., 2002), leaving only intrinsic spinal circuitry
to account for any recovery in cases of complete SCI such as
used in the animal models described here. Thus, there is an
obvious need to understand in detail the patterns of rhythmic
activity which the endogenous cholinergic propriospinal sys-
tem can produce, and to determine the receptor(s) involved.
Further, although atropine blocks the rhythmic motor activity
and excitation of motoneurons produced by cholinergic agonists,
there is currently no information about the muscarinic receptor
subtypes responsible for the cholinergic induction of rhythmic
activity in the neonatal rat. Here we show that enhancement
of the effects of the endogenous cholinergic propriospinal sys-
tem with an acetylcholine esterase (AChE) inhibitor can give rise
to well-coordinated locomotion, including alternation between
ipsilateral flexor and extensor motoneuron groups, in contrast
to the synchronous flexor/extensor activity commonly induced
by application of exogenous cholinergic agonists (Cowley and
Schmidt, 1994). We also provide evidence that M2 and M3
muscarinic receptors are involved in the cholinergic control of
locomotor activity.
After baseline recordings of 30 s duration, EDRO (25–
100μM) was applied to the bath. Episodes of rhythmic activ-
ity (Figures 1A,B), with superimposed slower rhythms, were
produced in 88% (64/73) of experiments after a period of
5–370 s (mean ± SD; 69.9 ± 75.5 s). In the remaining nine
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FIGURE 1 | Episodes of rhythmic activity are induced after bath
application of EDRO. (A) EDRO applied to the bath 30 s after the onset of
the recording induced episodes of rhythmic activity with waxing and waning
amplitude of the signal in all channels for several minutes. (B) Expanded
sample from the same recording showing episodes of rhythmic activity (the
area indicated by vertical lines) separated by periods of decreased activity.
(C) Expanded sample of the recordings in (B) (the area indicated by vertical
lines) showing well-coordinated locomotion characterized by alternating
flexor/extensor (L2/L5) and right/left ENG activity (r/l).
experiments, the activity was either tonic or was observed in
one or two ventral roots only. In 44 of the 64 experiments in
which EDRO produced rhythmic activity (69%), the activity
consisted of sustained patterns of ventral root activity character-
ized by right/left and ipsilateral flexor/extensor alternation typical
of locomotion (Figures 1C, 2). The mean number of episodes
of locomotion was 6.5 per 30min recording period. The mean
duration of each episode of activity was 110.4 ± 56.1 s (range
50–184 s). Themean rhythm frequency was 0.21± 0.05Hz (0.13–
0.33Hz), and the mean step duration was 4.90 ± 1.31 s (range
1.8–7.8 s).
Besides locomotion, episodes of ipsilateral flexor/extensor
and right/left synchrony, episodes of ipsilateral flexor/extensor
synchrony but alternating right/left sides, episodes of right/left
synchrony and ipsilateral flexor/extensor alternation, or a com-
bination of these patterns were observed, often within the same
experiment. No relation was observed between the concentra-
tion of EDRO applied and the type of pattern produced in these
experiments.
A second AChE inhibitor, NEO (25μM), was also effective in
inducing locomotor-like activity in the 2 experiments in which
it was applied (data not shown). The mean rhythm frequency
(0.22 ± 0.017Hz), duration (4.51 ± 1.02 s) and number of
episodes, 4 per 30min recording, were similar to that produced by
EDRO. However, the mean duration of each episode was 267.5 ±
488.4 s (range 20–1000 s), a more than two-fold increase over the
EDRO induced locomotion. These results confirm that decreas-
ing the breakdown of ACh in the spinal cord is sufficient to trigger
locomotor activity.
In order to determine if the rhythmic activity produced
by EDRO was locomotor-like, 19 of the best 44 experiments
were chosen for analysis of coordination among the ventral
root recordings. Raw ENG waveforms (Figure 2A) were rectified
and filtered for detailed analysis to determine the relationships
between flexor/extensor and right/left activity (Figure 2B). Polar
plots (Figure 2C) were produced from the rectified and filtered
waveforms from this example (red vectors), showing the flexor
and extensor ENGs (r L2 vs. r L5) were out of phase (θ = 205◦).
The right and left flexor ventral root ENGs (r L2 vs. l L2) were
also out of phase (θ = 201◦), indicating right/left alternation.
Successive steps extracted from the rectified and filtered wave-
forms in Figure 2B were aligned with the onset of r L2 activity
and overlaid (Figure 2D) to demonstrate the consistent alter-
nation between flexor (L2) and extensor (L5) and left (l) and
right (r) waveforms. The mean rhythm frequency in this exper-
iment was 0.21Hz and the mean duration of each step cycle was
4.88 ± 0.64 s.
Figure 2C also shows the mean angles (green vectors) in
degrees and the mean r-values of right flexor/extensor alter-
nation and right/left alternation for the 19 experiments (black
vectors). The overall mean angle for flexor/extensor alternation
(r L2 vs. r L5) was 170.0 ± 25.4◦ (124.9◦–206.5◦), r = 0.84 ±
0.1 (0.66–0.98). The overall mean angle and the mean r-value
right/left alternation (r L2 vs. l L2) was 186.1 ± 21.94◦ (153.6◦–
235.1◦), r = 0.87 ± 0.08 (0.67–0.96). These data indicate that
well-coordinated locomotion occurred consistently with EDRO
enhancement of the endogenous cholinergic system, without any
requirement for cross-wavelet/coherence analysis to reveal “hid-
den” patterns of activity, as suggested by Lev-Tov and co-workers
(Anglister et al., 2008).
THE EFFECTS OF ACh RECEPTOR (AChR) ANTAGONISTS
Nicotinic antagonists
In order to determine which AChR subtype is required for
EDRO induced locomotion, we conducted experiments with both
nicotinic and muscarinic antagonists. The non-specific nicotinic
antagonist tubocurarine was used and had no effect in 8 exper-
iments at concentrations of 1–20μM, up to 70 times the Ki
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FIGURE 2 | Induction of locomotion in vitro by 50 µM EDRO. (A) ENG
recordings showing sustained alternating flexor/extensor and left/right
activity. (B) Rectified and filtered waveforms of the traces in (A). (C)
Polar plots derived from pooled data from 19 experiments showing the
circular distribution of mean phase values and mean angles of the right
flexor ventral root ENG (r L2) vs. the right extensor ventral root ENG (r
L5), and right (r L2) vs. left (l L2) flexor ENGs (green vectors). The
superimposed r vectors show the concentration of phase values around
the mean angle. Mean rhythm frequency (Hz) of all filtered and rectified
r L2 waveforms: 0.213 ± 0.052Hz (0.13–0.33Hz). Mean step duration of
all rectified and filtered r L2 waveforms: 4.908 ± 1.312 s (4.85–7.87 s).
The phase value for ipsilateral flexor/extensor activity (θ = 205◦) as well
as the bilateral flexor (r L2 vs. l L2) phase value (θ = 201◦) for the
example shown in (A,B,D) is shown in (C) with the red vector. (D)
Overlay of step cycles (triggered on the onset of l L2 activity) of each
rectified and filtered waveform shown in (B).
of tubocurarine (280 nM) (Khan et al., 1994). It can therefore
be concluded that EDRO-induced locomotion does not require
nicotinic receptors.
Muscarinic antagonists
To determine if muscarinic receptors have a role in EDRO-
induced locomotion, we examined the effects of the non-specific
muscarinic antagonist atropine. Atropine has high affinity for
all M receptor subtypes. In each of six experiments atropine
decreased the amplitude of ENG bursts and blocked locomotion
at concentrations from 105 nM to 1μM. This result indicates that
muscarinic receptors are required for the locomotion produced
by EDRO, confirming previous observations (Smith et al., 1988a).
In addition, however, we found that in 4 of 6 preparations prior
to blocking locomotor activity completely, atropine produced an
initial increase in the frequency (not burst amplitude) of locomo-
tion that persisted until locomotion ceased (up to 16min after
the addition of atropine). The mean frequency prior to atropine
was 0.207± 0.06Hz, while after atropine treatment the frequency
increased to a mean of 0.28 ± 0.06Hz. This is a highly signif-
icant change (p < 0.003). This effect is shown in Figure 3A. In
many cases the duration of the episode was prolonged, further
suggesting a facilitatory action of atropine. This was not system-
atically investigated, however. To determine which muscarinic
receptor subtypes might account for the effects of atropine,
we examined the effects of antagonists to M1(telenzepine), M2
(methoctramine), M3 (4-DAMP) and M4 (MT-3) receptors. The
M5 receptor was not examined because M5 receptors have not
been observed in the ventral horn of the neonatal rat spinal cord
(Wilson et al., 2004).
M1 receptor antagonist
The M1 receptor antagonist telenzepine was used in 12 experi-
ments, starting with concentrations of 500 nM and increasing in
concentration to 20μM. Telenzepine failed to block locomotion
at concentrations of 500 nM to 5μM, (500–5000 fold greater than
Ki). Telenzepine blocked EDRO induced locomotion only when
the concentration reached 20μM, (20,000 fold higher than Ki).
In all cases where telenzepine blocked EDRO induced locomo-
tion, the amplitudes of the ENG bursts were decreased but the
frequency of stepping was not consistently altered (Figure 3B1).
This implies that the action of telenzepine was not on CPG ele-
ments responsible for producing the locomotor rhythm, but on
cells involved in controlling the output of motoneurons, or on the
motoneurons themselves. The high doses required for telenzepine
to effectively block locomotion imply that the effect was not due
to a specific action at the M1 receptor, but more likely because it
also has affinity for the M2 receptor, found on cholinergic pro-
priospinal cells and on motoneurons, or because it has affinity at
higher doses for the M3 receptor. As noted below, the potent M3
receptor antagonist 4-DAMP blocks EDRO-induced locomotion
at doses in the nanomolar range.
M2 receptor antagonist
We tested the M2 receptor antagonist methoctramine
(METHOC) in 14 experiments with concentrations from 1
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FIGURE 3 | Atropine, telenzepine, and methoctramine effects on the
EDRO-induced locomotor rhythm. (A1) Rectified and filtered waveforms
showing atropine block of EDRO-induced locomotion. (A2) Baseline
locomotor-like activity. (A3) Transient increase in frequency and a
decrease in amplitude after 1μM atropine. (A4) Progressive reduction of
EDRO-induced activity by atropine. (B1) Telenzepine (20μM), an M1
receptor antagonist, blocks EDRO-induced locomotor-like activity only at
high doses, decreasing the amplitude but not the frequency of the ENG
activity. (B2–B4) Methoctramine (METHOC, M2 receptor antagonist)
produces an increase in frequency of EDRO-induced locomotion at
1–2μM. (B2) Rectified and filtered waveforms recorded from the right L2
and L5 ventral roots produced by 100μM EDRO. (B3) Baseline
locomotor-like activity recorded during the period indicated by the
horizontal bar below the ENG trace in (B1). (B4) Increase in frequency of
the ENG bursts resulting from a cumulative dose of two 1μM METHOC
(period indicated in B2).
to 50μM. When applied to the chamber in concentrations from
1 to 2μM (100–200 fold higher than Ki) METHOC seldom
blocked locomotion. At these doses, METHOC produced a
striking increase in the frequency of the locomotor bursts
(Figures 3B2–B4). This effect was observed in 6 of 9 trials.
The mean frequency prior to METHOC was 0.19 ± 0.03Hz,
while after METHOC treatment the frequency increased to a
mean of 0.33 ± 0.04Hz. This is a highly significant change
(p < 0.001). These results suggest that METHOC relieves some
form of muscarinic action that suppresses locomotion, perhaps
through an inhibitory action on locomotor neurons, or through
an excessive excitatory drive to CPG neurons that would serve
to prolong each phase of the locomotor cycle. This is very likely
through actions on the M2 receptors, because METHOC has a
rather low affinity for M1, M3, and M4 receptors. These results
are consistent with M2 receptor mediated suppression of CPG
activity. At a concentration of 2–50μM (200–3000 fold higher
than Ki) METHOC was able to suppress locomotion (5 of 9
trials). As with telenzepine, in every case where METHOC
blocked EDRO-induced locomotion, ENG amplitude was
decreased (Figure 3B4). This is consistent with an action directly
on motoneurons, which are known to possess M2 receptors
(Hellstrom et al., 2003). The importance of these receptors has
been recently reviewed (Brownstone, 2006; Miles and Sillar, 2011;
Witts et al., 2014).
M3 receptor antagonist
Themuscarinic antagonist 4-DAMPwas chosen due to a reported
high affinity for the M3 receptor subtype (Michel et al., 1989). In
12 experiments, 4-DAMP blocked locomotion at concentrations
of 3, 10, 100, 500 nM, and 1μM. Figure 4A shows a typical exam-
ple of EDRO-induced locomotor activity. In this example, the
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FIGURE 4 | EDRO-induced locomotion is blocked by 4-DAMP. (A) 50μM
EDRO induced a sustained pattern of locomotion. (A, right panel) Polar Plots
of flexor-extensor and left/right alternation show highly coordinated
locomotion prior to the application of 4-DAMP. (B) 4-DAMP applied to the
bath decreased rhythm frequency from 0.178 to 0.063Hz followed by
complete blockade of rhythmic activity. An additional dose of EDRO (100μM)
failed to induce locomotion (data not shown), but adding 1μM 5-HT to the
bath produced tonic firing followed by locomotor-like activity. The fact that
5-HT can “rescue” locomotor-like activity despite continued block of the
EDRO effect shows that the preparation remained viable and that M3
receptor blockade did not interfere with locomotion induced by 5-HT. (C,D)
Comparison of the effects of 4-DAMP on EDRO-induced locomotion with
hind limbs attached (C) or removed (D). The right panels show the results
from the application of 4-DAMP in the two preparations.
hindlimbs were attached and moved during episodes of locomo-
tor activity. Subsequent addition of 4-DAMP (10 nM) to the bath
slowed the locomotor rhythm and eventually blocked it com-
pletely (Figure 4B). After wash-out, a subsequent dose of EDRO
(100μM) had no effect. In order to demonstrate that the prepa-
ration was still capable of producing locomotion, 1μM5-HT was
then added to the bath (Figure 4B).Well-coordinated locomotion
was induced, indicating that the locomotor CPG could still be
activated in the absence of recovery of the EDRO effect. In each of
the experiments where 4-DAMP blocked locomotion, subsequent
application of EDRO, at its maximum concentration of 100μM,
failed to re-establish locomotion or induce any rhythmic activity.
In experiments where the hindlimbs were removed and 4-
DAMP was applied to the isolated spinal cord alone (n = 8),
the outcomes of 4-DAMP application on the locomotor cycle
characteristics (frequency and amplitude) were similar to those
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obtained with hindlimbs attached (n = 4). Examples of 4-DAMP
effects on locomotor frequency in these two preparations are
shown in Figures 4C,D. The mean step frequency of EDRO-
induced locomotion before 4-DAMP with hindlimbs attached
(Figure 4C, left panel) was 0.176Hz and the mean step frequency
after 4-DAMP was applied and before complete cessation of loco-
motion (Figure 4C, right panel) was 0.068Hz. The mean step
frequency of EDRO-induced locomotion before 4-DAMP with
hindlimbs removed (Figure 4D, left panel) was 0.134Hz and the
mean step frequency after 4-DAMP was applied (Figure 4D, right
panel) was 0.055Hz. ENG amplitude decreased in all experi-
ments using 4-DAMP. This suggests that the effect of 4-DAMP
may be on neurons intrinsic to the spinal cord, rather than on
the relay of sensory signals from the moving limb. The decrease
in step frequency is consistent with M3 receptor involvement in
the cholinergic activation of cells within the locomotor network.
Unlike atropine and METHOC, 4-DAMP did not produce even a
transient increase in the frequency of locomotion.
Importantly, 4-DAMP was effective at doses as low as 3 nM.
This finding demonstrates that 4-DAMP, in contrast to the M1
and M2 antagonists, blocks EDRO-induced locomotion near its
Ki, thus implicating the M3 receptor as the most likely muscarinic
receptor subtype responsible for EDRO-induced locomotion in
the in vitro neonatal rat preparation.
M4 receptor antagonist
MT-3 was tested in three experiments with concentrations from
5, 10, and 300 nM (1.6 fold lower and 35 fold higher than Ki).
It had no effect on EDRO-induced locomotion in any of these
cases (data not shown). It is unlikely, therefore, that theM4 recep-
tor is involved in the locomotor activity produced by enhancing
the effects of the endogenous cholinergic propriospinal system
with EDRO.
These results show that the endogenous cholinergic pro-
priospinal system is capable of producing coordinated locomotor
activity, and that under the conditions of our experiments the
control of motoneuron excitability is mediated by M2 receptors,
while the rhythm generating component is controlled by M3
receptors. This raises the possibility that this endogenous spinal
system might contribute to the locomotion in the intact animal
and to recovery of locomotion after SCI.
INTRAVENOUS CHOLINERGIC ANTAGONISTS—DECEREBRATE CATS
In order to test the importance of both the brainstem cholinergic
nuclei implicated in the initiation of locomotion and the endoge-
nous cholinergic propriospinal system we used intravenous appli-
cation of cholinergic antagonists in decerebrate cats. We elicited
locomotion with stimulation of the MLR. Because both nicotinic
and muscarinic receptors have been implicated in the relay of
the locomotor command from theMLR to reticulospinal neurons
(Ryczko and Dubuc, 2013), we tested antagonists to both types of
receptors. These experiments also provided a test of whether the
intrinsic cholinergic propriospinal system is normally recruited as
a component of the locomotor CPG in adult animals.
Previous work on decerebrate cats showed that MLR-evoked
locomotion could be abolished with injections of cholinergic
antagonists into a specific site in the medulla that receives
cholinergic input from the MLR (Garcia-Rill and Skinner, 1987).
Whether this is an obligatory route for evoking locomotion
has not been tested, however. Here we show (Figure 5) that
intravenous infusion of atropine and/or mecamylamine did not
abolish MLR-evoked treadmill locomotion in any of the exper-
iments (n = 15). Administration of mecamylamine alone pro-
duced slight increases in the threshold for electrically induced
locomotion that were within the range of normal variability for
lengthy experiments on decerebrate animals (114, 116, 119 and
133% of control) in 4/7 experiments. No change was observed
in two experiments and a decrease in the threshold (to 63%
of control) was observed in the remaining one. Atropine given
alone produced a transient increase in threshold (111% of the
projected baseline) in one experiment and had no effect in one
other. The effect of a combination of atropine andmecamylamine
on the threshold for electrically induced locomotion was exam-
ined in 5 experiments. Aside from a transient increase (5–8min)
in locomotor threshold coinciding with a drop in blood pres-
sure, no change in threshold outside of the normal variability
was observed (100, 104, 130, 131, and 131% of control trials)
after administration of both drugs. In four animals brief peri-
ods of spontaneous locomotion were present both prior to and
after infusion of atropine and/or mecamylamine. The thresh-
old for electrically-induced locomotion (outside of the normal
variability) was transiently increased (5–8min) in 5 animals
after administration of mecamylamine or both drugs together.
Since intravenous administration of atropine or mecamylamine
(at the doses used in the present study) has a prolonged effect
(Ueki et al., 1961; McCance et al., 1968b; Lake, 1973; Ryall and
Haas, 1975; Noga et al., 1987) these brief increases in thresh-
old are attributed to the transient decreases in blood pressure
observed following administration of these drugs. Thus, no evi-
dence for blockage of either spontaneous or MLR-induced loco-
motion bymecamylamine or atropine was obtained in the present
experiments.
Figure 5 illustrates the EMG activity recorded in a typi-
cal experiment prior to and after administration of mecamy-
lamine and atropine. The lowest threshold MLR stimulation site
(Figure 5A) located in the cuneiform/subcuneiform nucleus was
in close proximity to the cholinergic cell group hypothesized to be
functionally relevant to the production of locomotion (Garcia-
Rill and Skinner, 1987; Garcia-Rill et al., 1987). The muscle
activity persisted with the normal timing relationships among the
muscles maintained in spite of the administration of mecamy-
lamine (Figure 5C) and atropine (Figure 5D) at doses appropri-
ate for the blockage of nicotinic and muscarinic transmission.
In this example, the thresholds for initiation of locomotion by
electrical stimulation of the MLR did not increase but rather
decreased after drug administration.
In order to determine the effect of the drugs on the over-
all levels of motor unit activity produced during locomotion,
averaged EMG records obtained following drug administration
were compared to those recorded during control trials. In 285
trials where TA and GL muscle activity was examined, mecamy-
lamine produced an increase in EMG burst activity in 3 (1.1%),
a decrease in 20 (7.0%) and no change in EMG burst activ-
ity in 262 (91.9%). Of the 38 trials with atropine an increase
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FIGURE 5 | Effect of mecamylamine and atropine on locomotion induced
by electrical stimulation of the MLR. (A) Site of stimulation was localized
to the ventrolateral border of the cuneiform nucleus (CNF) near the brachium
conjunctivum (BC) at P2, L4, H-1.5 (coordinates according to Berman, 1968).
(B) Treadmill locomotion evoked from this brainstem site prior to any drugs
(stimulus strength of 135μA); (C) following the infusion of mecamylamine
(3mg/kg, stimulation strength 60μA) and (D) following atropine (2.5mg/kg,
stimulation strength 70μA). Thresholds for the initiation of locomotion for
(B–D) were 150, 150, and 75μA, respectively. The gain of each muscle’s
EMG is the same throughout all trials.
of activity in 6 (15.8%), a decrease in 3 (7.9%) and had no
effect in 29 (76.3%) was observed. Combined administration
of atropine and mecamylamine produced an increase in muscle
activity in 14/142 trials (9.9%), a decrease in 5/142 trials (3.5%)
and had no effect on muscle activity in 123/142 trials (86.6%).
It is clear from these data that the amount of muscle activity as
measured from the area of the burst during the normalized step
cycle was not altered in any consistent manner by cholinergic
blockade.
We examined the effects of the drugs on the burst dura-
tion and times of onset and termination of EMG activity during
the step cycle. In 315 trials on 6 muscles (TA, GL, IP, AF, TB,
and BB), mecamylamine produced an increase in burst dura-
tion in 81 (25.7%), a decrease in 60 (19.1%) and no change
in 174 (55.2%). For 88 trials, atropine produced an increase in
burst duration in 33 (37.5%), a decrease in 11 (12.5%), and
had no effect on burst duration in 44 (50.0%). It is evident
from this analysis that cholinergic blockage did not consistently
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alter the duration of EMG activity in any of the muscles
examined.
These data reveal that in adult decerebrate cats there appears
to be no requirement for cholinergic neuron participation in the
initiation or coordination of locomotion at either the brainstem
or the spinal cord levels, using i.v. application of drugs known
to cross the blood-brain-barrier for testing the actions of mus-
carinic and nicotinic receptors. In agreement with this, it appears
that the cholinergic C-boutons on motoneurons do not provide
a major component of the locomotor drive (Witts et al., 2014),
consistent with our finding that blockage of muscarinic inputs to
motoneurons in adult cats does not alter the amplitude of EMGs
recorded from hindlimb motoneurons. It is still possible, how-
ever, that cholinergic neurons of the spinal cord participate in the
recovery of locomotor activity after SCI. Since this propriospinal
system is a major intrinsic system known to facilitate locomotion
that is spared by SCI, we hypothesized that it could be responsible
for locomotor recovery. To establish this, we examined the effects
of intrathecal cholinergic agonists and antagonists on locomotor
recovery in cats and rats after spinal cord transection.
SPINAL CATS
An initial set of experiments was conducted in 2 spinal cats
prepared so that intrathecal (i.t.) injections of various agonists
(carbachol) or the AChE inhibitor EDRO, as well as antagonists
such as atropine, 4-DAMP and dihydro-β-erythroidine could be
injected in volumes of 100μl (unless specified otherwise) in
both cats on alternate days, thus keeping the time sequence of
injections after spinalization approximately the same.
Early chronic period (5–14 days)
On Day 5 and 6 post lesion, the animal was placed on a tread-
mill running at 0.3m/s. As expected, only faint movements were
evoked by strong perineal stimulation and sporadic tonic hyper-
flexion of both hindlimbs but without any locomotion. This is
illustrated in Figure 6A where stick figure reconstructions of the
movements over consecutive seconds is shown (top panel), as
well as the corresponding angular excursion of the joints (middle
panel) and EMGs (bottom panel).
EDRO was then given i.t. (each application in a bolus of
100μl) in two cats (in one 0.5mM then another 0.5mM 13min
later, in another 1 dose of 2mM directly) and the effect moni-
tored each 10min over a 30–40min period by holding the cat
over the treadmill belt and by applying various skin or perineal
stimulation to facilitate locomotor movements. No obvious effect
was observed after EDRO (compare Figures 6A,B). Acetylcholine
was then given (in one cat 1mM; in the other 2mM) 45min
after EDRO and again, no locomotor movements were observed
(Figure 6C) for the next 1:30 h. To test the ability of the spinal
cat to generate locomotion, 100μg of clonidine was given i.t.
and vigorous stepping was triggered for the next 2 h, from 0.3
to 0.7m/s. As shown in Figure 6D, 6min after clonidine, alter-
nation between extensor and flexor muscles in each limb and
alternation of the activity of right and left homologous muscles
FIGURE 6 | Neither EDRO nor ACh in the presence of EDRO facilitated the
onset of locomotor activity in a spinal cat. (A) Pre-drug records of a cat
walking on a treadmill with strong exteroceptive stimulation used to activate
the locomotor CPG. Stick figures of the limb trajectory over 5 s of activity,
along with the corresponding joint angles and EMG recordings are illustrated.
(B) Similar records taken 35min. after 4mM EDRO administration. (C)
Recordings taken 1 h after administration of 2mMACh and 2h after the original
dose of edrophonium. (D) Subsequent dose of clonidine (3.8mM) elicited
typical stepping movements on the treadmill, as illustrated by joint angles and
EMG, showing that the animal was capable of producing locomotion.
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lead to a regular pattern of locomotion on the treadmill involving
all 4 joints. The cat walked with the limb somewhat in exten-
sion as should be expected only 5 days after spinalization. This
was seen in both cats and was repeated the day after (6 days post
lesion) in one cat with a higher dose of EDRO (4mM) and higher
doses of acetylcholine (4mM). In the other cat, higher dose of
EDRO (4mM) only, without acetylcholine, was tested to observe
the effect of the acetylcholinesterase alone and again, no obvious
effect was observed while clonidine could still trigger locomotion
when injected after all the other drugs. It is thus clear that the
AChE inhibitor produces no significant effect on the initiation of
locomotion in spinal cats, unlike its effects in the isolated neona-
tal rat spinal cord. ACh deteriorates the already poor stepping
and clonidine evokes a sustained locomotor pattern indicating
that cats were capable of walking and suggesting that the nega-
tive effects obtained with cholinergic stimulation was not due to
the inability of the spinal cats to walk.
On Day 8, after only 1 day of training (3 times for 5min),
the cholinergic agonist carbachol (1mM) was tested in both cats.
Before drug administration, one cat could make a few steps on
the treadmill with foot contact on the dorsum of the foot at
0.3m/s (not shown). After carbachol, standing was exaggerated
with hyper-extensions of the joints and stepping was completely
blocked within 7min. Thirty minutes later, perineal stimulation
evoked hyperflexions and a few steps with prolonged extension
but this type of movement was far from the locomotor pattern
observed before drug. In the other cat, locomotion was still not
possible before carbachol (Figure 7A). With carbachol, perineal
stimulation produced long duration discharges (several seconds)
of several muscles often simultaneously (Figure 7B). Overall, car-
bachol administration was tested 4 times in the two cats and it is
clear that carbachol could not trigger locomotion and was even
detrimental to the faint spontaneous locomotor pattern in the cat
when present.
On days 12–13, the cats began to show some recovery of loco-
motion (a few steps at 0.3–0.4m/s) when the perineum was
stimulated. At a higher speed, the animal showed some hyperflex-
ion of both hindlimbs even with stronger perineal stimulation. As
illustrated in Figure 8A, at a treadmill speed of 0.4m/s, the cat
cannot place its paw in front of the hip at the end of the swing
phases and there is a paw drag in the first part of the swing phase
(Figure 8A). The averaged EMGs show that although there is a
good alternation between flexor and extensor muscles, like St and
VL, Srt muscles on both sides have a very weak level of activity.
With this background of spontaneous activity, atropine was
injected with the hypothesis that the deterioration of walking seen
with ACh, carbachol or EDRO early after spinalization might be
due to an already extant hyper-cholinergic state. Twelve minutes
after drug administration (Figure 8B), the cat not only showed a
better pattern of locomotion, it could express locomotion with-
out the need of perineal stimulation. It could walk up to speed
of 0.6m/s. After 36min the cat could reach treadmill speeds up
to 0.8m/s (Figure 8C). These effects could still be seen after 3
hours (Figure 8D). Figure 8E illustrates the speeds that could be
reached by the cat at various time points after atropine injec-
tions. The averaged EMGs show a clear increase in the Srt muscles
resulting in a greater flexion of the knee and a better elevation
of the foot in the second portion of the swing phases before
the paw contact, as illustrated. When carbachol was added, the
spontaneous stepping was degraded although a few steps could
be triggered with strong perineal stimulation at a max speed of
0.5m/s without adequate limb extension or placement of the paws
(data not shown).
Thus, at 12 days the cat is already capable of performing a few
spontaneous steps. With atropine locomotion became more vig-
orous and 36min later the cat could walk up to 0.8m/s. Carbachol
dramatically degraded this locomotor activity.
Day 14: carbachol followed by atropine
At Day 14, the spinal cats could walk spontaneously (with-
out drugs) up to a treadmill speed of 0.7m/s. After carbachol
(Figure 9) the steps deteriorated with less weight support and no
FIGURE 7 | Carbachol, a cholinergic agonist, produced
co-contractions and interfered with locomotor activity early after
injury. (A) Pre-drug trial with EMG activity produced by perineal
stimulation. (B) 1 h 45 after i.t. carbachol (1mM, 100μl)
administration, perineal stimulation produced uncoordinated rhythmic
activity.
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FIGURE 8 | Intrathecal atropine facilitated locomotion in spinal cats.
(A–D) show kinematic and EMG recordings of a cat walking on a treadmill at
increasing time after atropine (1mM, 100μl) administration: stick figures of
one step cycle (top), averaged angular excursion of the four joints over
N > 12 step cycles (middle) and corresponding averaged rectified EMG
traces (bottom). The cycle is normalized to 1 and is repeated twice (separated
by doted vertical lines) for clarity at turning points. The average is
synchronized with the contact of the left foot (LC). (A) Pre-drug recordings at
a treadmill speed of 0.4m/s; (B) 12min after atropine administration at a
treadmill speed of 0.6m/s; (C) 36min after atropine at a treadmill speed of
0.8m/s; (D) 3 h after Atropine at a treadmill speed of 0.7m/s. (E) Cycle
duration as a function of treadmill speed, showing a maximal increase in
treadmill speed the cat could follow after atropine at approximately 30min,
with a slight decrease at 3 h after drug administration.
foot placement at 0.3m/s and perineal stimulation was required
to improve stepping at speeds ranging from 0.3 to 0.7m/s. Twenty
minutes after carbachol the cats could walk from 0.3 to 0.7m/s
with perineal stimulation but could not walk without it at 0.4m/s.
This deterioration of locomotion by carbachol could be
reversed by atropine. The cat could indeed walk from 0.4 to 0.6
without perineal stimulation with more forward movements of
the hindlimbs. Twenty minutes later the cat could walk as fast as
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FIGURE 9 | Carbachol disruption of locomotion in spinal cats is reversed
by atropine. (A–C) regular stepping movements before drug administration
14 days after the lesion represented by raw EMG traces (A), averaged
(N = 12 cycles) joint angular displacements (B) and stick figures (C). (D) Raw
EMG recordings after intrathecal carbachol (1mM, 100μl) showing
deterioration of stepping as soon as 7min post drug administration even with
strong perineal stimulation. (E,F) 55min post carbachol, the EMG is still not
organized to produce a good stepping pattern (E). There is no foot placement
as represented by the stick figures (F). (G–I) Five minutes after intrathecal
administration of atropine (1mM, 100μl), a good pattern of stepping was
observed without perineal stimulation as was the case before carbachol
administration [compare (G–I) with (A–C) same display]. (J) Cycle duration
expressed in terms of treadmill speed, showing disruption of locomotion by
carbachol, and facilitation of locomotion with atropine.
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0.9m/s without perineal stimulation (Figure 9J). Thus, in a walk-
ing spinal cat, carbachol disrupts locomotion but the locomotor
ability could be rescued by injecting atropine.
Late chronic period (>2 months)
In the late period (around 2 months) we injected a mus-
carinic blocker, 4-DAMP or a nicotinic antagonist, dihydro-β-
erythroidine. At this time, the cat still had appreciable loco-
motor activity in both hindlimbs, however, they needed more
perineal stimulation. After injecting 4-DAMP (45μg in 100μl,
M3 muscarinic receptor antagonist), the locomotor activity was
much improved, several sequences without perineal stimula-
tion could be obtained, and the cat could often walk without
any external weight support. Similar results were obtained using
dihydro-β-erythroidine (26μg in 100μl i.t.), which produced
long sequences of unaided spinal stepping. This was observed
in 5 trials in 2 chronic spinal cats (40–97 days post SCI). Thus,
the cholinergic suppression of spinal locomotion involves both
muscarinic and nicotinic receptors (data not shown).
CHRONIC SPINAL RATS
The above results indicate that despite the ability of endogenous
release of ACh in the neonatal rat cord to give rise to well-
coordinated locomotion, our hypothesis that locomotor recovery
after SCI could be mediated by increased activity of the intrinsic
cholinergic propriospinal system was not confirmed. In fact, the
data suggest that a hyper-cholinergic state might develop after SCI
that somehow interferes with locomotion. In order to test whether
this is a consistent feature of SCI across species, and to rule out the
possibility that our results in adult spinal cats might deviate from
our expectations based on the neonatal rat data due to a species
difference, we investigated the effects of intrathecal applications
of cholinergic drugs in adult spinal rats 10 weeks after injury.
Figure 10 shows a typical example of the effects of i.t. carba-
chol (1mM, 20μl) followed by an application of atropine (1mM,
20μl). We consistently observed a dramatic and immediate ces-
sation of treadmill locomotion induced by tail pinching when
carbachol was administered (n = 3) that lasted for several hours.
A subsequent i.t. application of atropine (in 10–15min after the
carbachol) reversed this effect and actually increased the efficacy
of tail stimulation to elicit locomotion. Plantar stepping was occa-
sionally induced (Figure 10C), and rhythmic activity persisted
even when there was no tail stimulation. Doses of 20μl of car-
bachol of 0.5 and 0.25mM were also effective. Thus, the effects of
carbachol and atropine in the spinal rat were remarkably similar
to the effects of these drugs in the adult spinal cat (Figure 9).
Therefore, our data provide evidence for a hyper-cholinergic
state in both cats and rats after SCI, with no evidence for a species
difference that might account for the unexpected absence of the
locomotion promoting action of the cholinergic propriospinal
system observed in neonatal rat preparations. An obvious differ-
ence between these two preparations is the presence of cutaneous
receptor feedback (Bouyer and Rossignol, 2003a,b; Sławin´ska
et al., 2012) in the spinal rats and cats walking on a treadmill. The
proprioceptive feedback from themoving limb (Pearson, 2004) in
neonatal rat preparations with the hindlimbs attached is not suf-
ficient to account for the differences, because the results were not
FIGURE 10 | Carbachol disruption of locomotion in spinal rats is
reversed by atropine. The left panels show representative frames from
the videos taken during the time of the corresponding EMG activity (right
panels). (A) Irregular stepping movements produced with tail stimulation
prior to drug administration. As shown in the left panel, the EMG activity
did not give rise to plantar stepping. The toes were always dragging on the
treadmill surface during rhythmic alternating activity. (B) Intrathecal
carbachol (1mM, 20μl) eliminated all stepping movements immediately,
and only a few sporadic episodes of largely synchronous bursting occurred
(recording taken 1min after administration). (C) The intrathecal
administration of atropine (1mM, 20μl) 10min after carbachol treatment
restored alternating movement and led to occasional plantar stepping (left
panel). The EMG activity was more consistent, and occurred even in the
absence of tail stimulation. The recording was made 30min after atropine
was given.
distinguishable from preparations with no hindlimbs attached.
The other difference between these two preparations might be
that some plasticity in the cholinergic system and the changes in
the receptors induced by total transection in spinal chronic rats
are not present in neonatal spinal cord preparations.
ACUTE SPINAL CATS
Our experiments on chronic spinal animals led us to attempt to
determine whether the atropine effect could be observed acutely
after spinalization, or whether a period of time was necessary for
it to develop. We also wished to examine the actions of cholin-
ergic drugs on sensory input, since our results suggest that a
decreased response to sensory inputs may be one explanation for
the detrimental effects of cholinergic agonists and the facilitation
of locomotion produced by cholinergic antagonists.
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Effect of atropine alone
In all cats, atropine alone, whether given intrathecally (1mM,
70μl) at mid lumbar segments or in a bath covering L3-L4 spinal
segments, failed to evoke locomotion in acutely spinalized cats
or in 1-week spinal cats decerebrated on the day of the experi-
ment. This suggests that some plasticity in the cholinergic system
is required for the effects of cholinergic drugs in chronic spinal
animals (data not shown).
Effect of atropine on sensory input
The effect of atropine on the SP reflex was tested in 4 cats:
acute (n = 2), 24 h (n = 1) and 7 days (n = 1) after complete
section of the spinal cord at T13. The amplitude of the reflex
evoked by a stimulation of the SP nerve increased after atropine
(i.t., 70μg in 100μl) compared to control values. Figure 11A
illustrates the averaged (n = 25) rectified response in St, GL,
and TA muscles after stimulation of SP 1.5T, 3 pulses, 300Hz
FIGURE 11 | Atropine facilitates the cutaneous reflex responses evoked
by stimulation of superficial peroneal (SP) nerve. (A,B) SP facilitation by
intrathecal atropine (70μg, 100μl) 1 day after the complete section of the
spinal cord: (A) averaged (n = 25) rectified response in ST, GL, and TA
muscles after stimulation of SP (1.5T, 3 pulses, 300Hz) 300Hz before (dotted
line), 53 (thin gray line) and 92 (thick black line) min post atropine; (B)
illustrates the evolution of the response amplitude of the SP reflexes as a
function of control responses in 4 muscles on the side of the stimulation.
(C,D) SP facilitation by atropine 1 week after SCI. Atropine 1 and 2
correspond to intrathecal atropine (70μg, 100μl) whereas Bath Atropine 3
corresponds to a bath application of 1.5ml of a solution containing 1mg/ml of
atropine.
Frontiers in Neural Circuits www.frontiersin.org November 2014 | Volume 8 | Article 132 | 17
Jordan et al. Cholinergic control of locomotion
before (dotted line), 53 (thin gray line) and 92 (thick black line)
min post atropine in a cat spinalized 24 h before. Not only did
the reflex increase in amplitude, but the latency decreased in St
and GL.
Figure 11B illustrates the evolution of the response ampli-
tude of cutaneous reflexes as a function of control responses in 4
muscles on the side of the stimulation. Amplitude of St and Srt
responses significantly increased 200–300% above control level
early after injection of atropine. There was clearly also a second
phase of increased amplitude starting at about 40min and lasting
for at least 2 h after atropine injection.
Similar results were obtained in a 1 week spinal cat in
which atropine was applied over the L3-L4 segments. In this
case, the increase in reflex amplitude was obtained earlier, i.e.,
42min after intrathecal administration of atropine (Figure 11C).
In the other 1 week spinal cat, the increase was obtained
within the same delay as in the 24 h spinal cat, i.e., around
90min (Figure 11D). We tested whether locomotion could be
evoked by administration of a second dose of atropine in the
lumbar bath. As illustrated in Figure 11D, each time atropine
was given, the reflex amplitude increased (see at 180min).
However, as was the case in all cats detailed above, even this
larger dose of atropine and with strong exteroceptive stimula-
tion, no locomotion could be evoked. To test again whether
this spinal cat was able to walk at all, clonidine (150μg/kg,
i.v.) was given and within a short time the usual nice loco-
motor pattern was evoked and reflex threshold increased from
170 to 500μA as seen before with clonidine (Barbeau et al.,
1987).
Atropine facilitates clonidine induction of locomotion
The previous results suggest that perhaps atropine and clonidine
could have a synergistic effect, even at times after transection
when atropine alone is ineffective. In one cat bath applica-
tion of atropine was followed, 40min later, by a small dose
of i.v. clonidine. As was the case with the 4 above mentioned
cats, atropine at L3-L4 did not evoke locomotion but, a small
dose of clonidine (60μg/kg, i.v.) 40min after the atropine trig-
gered a vigorous pattern of locomotion. It thus seems that even
if atropine alone does not evoke locomotion, it acts synergis-
tically with clonidine since a minimal dose of clonidine that
normally fails to evoke locomotion can trigger the locomotor
rhythm.
Effect of clonidine followed by atropine
To further validate the facilitation of locomotion produced by
atropine, an even smaller sub-threshold dose of clonidine was first
given (20μg/kg, i.v.) and then atropine was given through a bath
over L3-L4 in a 4 day spinal cat, a 5 day spinal cat as well as in an
acute spinal cat. In all cases the dose of clonidine was insufficient
to evoke locomotor rhythm by itself. Figure 12 shows the EMG
activity 80min after clonidine injection and 40min after atropine
application. At 40 and 60min post atropine some bursts of
activity appear, but strong locomotor activity was observed only
110min post atropine (160min post clonidine). Similar results
were found in another semi-chronic cat and in one acute spinal
cat (Figure 13). This late activation of locomotion corresponds to
FIGURE 12 | The effect of a sub-threshold dose of clonidine is
facilitated by atropine. Clonidine was first given i.v. (20μg/kg) and then
atropine (1.5ml of a solution containing 1mg/ml of atropine) was given
through a bath covering the L3-L4 segments of the spinal cord 40min later
(Continued)
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FIGURE 12 | Continued
in a 4 days spinal cat. (A) EMG signals from hindlimbs muscles 80min after
clonidine injection and 40min after atropine application. Some bursts of
activity appear after atropine especially in the hip flexors (St); (B) 60min
after atropine some alternating activity appears between flexor and
extensor muscles but it was not organized enough to trigger strong
locomotion; (C,D) strong pattern of locomotion was observed 110 and
150min post atropine.
the time of the peak reflex amplitude observed in other cats with
atropine.
A plausible explanation for these results is that early after SCI
atropine is ineffective alone due to the absence of some plas-
ticity that increases muscarinic control of cutaneous input after
chronic injury. In the presence of low-dose clonidine, however, we
propose that a tonic cholinergic control of afferent input that sup-
presses feedback necessary for locomotion induction is already
present. Atropine blocks this suppression and thus facilitates
locomotion.
DISCUSSION
We first demonstrated in neonatal rat preparations that facili-
tation of the endogenous cholinergic propriospinal system can
result in coordinated locomotor activity, suggesting it may be a
substrate for recovery of locomotion after SCI. We demonstrated
that specific muscarinic but not nicotinic receptors are involved
in this process. We tested the importance of brainstem and spinal
cholinergic systems in the initiation of locomotion from the MLR
in adult decerebrate cats, and showed that systemic application of
neither nicotinic nor muscarinic antagonists could interfere with
MLR-evoked locomotion. We tested the hypothesis that cholin-
ergic propriospinal cells contribute to the recovery of locomotor
activity in spinal cats, and found that this hypothesis was not sup-
ported. Surprisingly, both nicotinic and muscarinic cholinergic
antagonists facilitated locomotion, suggesting the development
of a hyper-cholinergic state after SCI. The effects of carbachol
and atropine were confirmed in chronic spinal rats, showing that
the results obtained in the adult spinal cat were not due to a
species difference. Finally, we provided evidence that an under-
lying change in cholinergic contributions to spinal control of
locomotion was facilitation of the control of afferent input, so
that cholinergic antagonists were effective facilitators of spinal
locomotion. Different populations of cholinergic neurons that
may contribute to these effects are illustrated in cartoon form in
Figure 14. The actions of the various pharmacological agents on
the different preparations used in this study are summarized in
Table 1.
WELL-COORDINATED LOCOMOTION IS INDUCED IN VITRO BY
FACILITATION OF THE ENDOGENOUS CHOLINERGIC PROPRIOSPINAL
SYSTEM
The predominance of well-coordinated locomotion induced by
EDRO documented in these experiments provides the first clear
demonstration that facilitation of the effects of ACh released
from the endogenous cholinergic propriospinal system is suf-
ficient to activate the locomotor CPG in the isolated neonatal
FIGURE 13 | Sub-threshold clonidine is facilitatedby atropine in an acute
spinal cat. (A) Pre-drug records of EMG signals from hindlimbs muscles; (B)
20min after administration of a small volume of clonidine i.v. (20μg/kg); (C)
20min after bath atropine (1.5ml of a solution containing 1mg/ml of atropine)
over L3-L4 and 40min post clonidine; (D) 55min after atropine application, a
vigorous pattern of locomotion is represented by the EMG signals.
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FIGURE 14 | Cartoon showing different functional groups of
cholinergic neurons that are suggested by our results. A population for
afferent input control (AIC) is illustrated, some of which are known to have
direct presynaptic terminals on cutaneous afferents, as well as terminals on
GABAergic interneruons (not shown) that may also be responsible for
suppressing afferent input. AIC neurons act on their targets through both
muscarinic and nicotinic receptors. A population of cholinergic neurons
(LRC) that can control the locomotor rhythm by activating the central
pattern generator for locomotion (CPG) are also shown. Their precise
positions are unknown. They act on their target neurons via M3 receptors.
Pitx2 neurons give rise to C terminals on motoneurons and increase
motoneruron excitability by reducing the AHP amplitude via M2 receptors.
They are also known as V0c neurons. Commissural cholinergic interneurons
(CIN) are illustrated, many of which terminate on contralateral motoneurons
and produce EPSPs in motoneurons via M-currents blocked by atropine.
Other partition or central canal cluster cells with unknown function are
likely also present in the spinal cord.
rat preparation. Previous experiments with application of exoge-
nous ACh led to the conclusion that ACh-induced rhythmic
activity was seldom locomotor-like, due to the predominance
of ipsilateral flexor-extensor co-activation observed (Cowley and
Schmidt, 1994). Other studies also suggested that cholinergic acti-
vation does not induce locomotor-like activity in the neonatal
rat (Atsuta et al., 1991) or the mudpuppy (Fok and Stein, 2002)
spinal cord. In the “motor functionally mature” mouse spinal
cord, application of muscarine evoked irregular bursting in the
ventral roots, and no locomotion (Jiang et al., 1999). According
to Anglister et al. (2008), periods of well-coordinated locomo-
tor activity can be revealed in the neonatal rat in the presence
of EDRO and ACh, but only when coherent power analysis is
used to analyze the variable activity produced by the network.
Our detailed analysis of EDRO-induced locomotion presented
here, however, clearly establishes that endogenous cholinergic
activation is sufficient for the full expression of fictive loco-
motion. Similar results with another inhibitor of acetylcholine
esterase (NEO) confirm this conclusion. Sacral application of
EDRO has been shown to elicit locomotor activity in the lumbar
cord (Finkel et al., 2014), and this component of a sacrocau-
dal afferent system capable of eliciting locomotor activity may
have contributed to the results reported here. Our results sug-
gest that using cholinesterase inhibitors allows the expression
of cholinergic-induced rhythms triggered by release from the
intrinsic cholinergic neurons, rather than by application of an
exogenous agonist, to give rise to coordinated locomotion. This
suggests that certain actions of exogenous cholinergic agonists
may produce conflicting effects that actually interfere with the
production of coordinated locomotion including flexor-extensor
antagonist activity and right-left alternation. This could result for
instance from conflicting effects of agonists on afferent inputs
and central drive mechanisms. Locomotion induced by other
means, such as MLR stimulation (this study) or exogenous neu-
rochemicals such as 5-HT, dopamine and NMDA, is not antag-
onized by cholinergic blockers (Fok and Stein, 2002; Bertrand
and Cazalets, 2011) indicating some specificity of the cholinergic
antagonists used.
There is evidence for strong cholinergic influences on com-
missural cells (Carlin et al., 2006), and for cholinergic com-
missural cells that are active during locomotion (Huang et al.,
2000). Some commissural cells with excitatory actions on con-
tralateral motoneurons are cholinergic (Bertrand and Cazalets,
2011), and sacral cholinergic neurons modulate locomotor
activity recorded from the lumbar segments in vitro (Finkel
et al., 2014). A portion of these cholinergic neurons are
commissural. Exogenous cholinergic agonists may have the
effect of activating commissural cholinergic influences that
predominate, provided the ipsilateral coordinating interneu-
rons controlling flexor/extensor alternation are not so strongly
activated.
The cholinergic input to spinal neurons includes C-terminals
on motoneurons, which are now known to originate from V0c
neurons that are characterized by Pitx2 expression (reviewed in
Witts et al., 2014). They are active during locomotion, and they
increase motoneuron firing by reducing the AHP amplitude via
M2 muscarinic receptors (Miles et al., 2007; Zagoraiou et al.,
2009). Pitx2 V0c neurons provide cholinergic terminals on Ia
inhibitory interneurons (IaINs) (Siembab et al., 2010), the neu-
rons involved in reciprocal inhibition from primary afferent fibers
(Jankowska and Roberts, 1972). It is clear, based on the size of the
terminals, that those on IaINs are not C-terminals (Siembab et al.,
2010).
M2 RECEPTORS CONTROL MOTONEURON EXCITABILITY AND
LOCOMOTOR FREQUENCY
The reduction of ENG amplitude observed in the cases of antag-
onists with high affinities for M2 receptors (atropine, methoc-
tramine, and to a lesser extent telenzepine, and 4-DAMP) is
consistent with the presence of M2 receptors at cholinergic ter-
minals on motoneurons and with the finding that muscarinic
receptor activation increases motoneuron excitability. The effects
of various antagonists on the control of locomotion derived
from the present results are summarized in Table 1. In adult
mammalian motoneurons, cholinergic agents produce plateau-
like responses (Zieglgansberger and Reiter, 1974), consistent with
the muscarinic effects in the turtle spinal cord slice (Svirskis
and Hounsgaard, 1998; Guertin and Hounsgaard, 1999). In
other studies, cholinergic agonists have been shown to depolar-
ize rat motoneurons (Evans, 1978; Jiang and Dun, 1986) and
in mouse motoneurons, muscarinic receptor activation leads
to an increase in excitability, manifested by an increase in f-I
slope and a reduction in the post-spike afterhyperpolarization
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Table 1 | Summary of the effects of drugs altering cholinergic function in the various preparations used in this study.
Pharmacological agents Neonatal rat
spinal cord
preparation
Decerebrate cat
preparation
Acute spinal
cat
Early chronic
spinal cat
Late chronic
spinal cat
Late chronic
spinal rat
Edrophonium (EDRO)
AChE inhibitor
↑↑ ↔
Neostigmine (NEO)
AChE inhibitor
↑↑
EDRO + ACh
AChE inhibitor + acetylocholine
↔
EDRO + tubocurarine
AChE inhibitor + nicotinic antagonist
↔
Clonidine
NA agonist
↑↑
EDRO + clonidine
AChE inhibitor+ NA agonist
↑↑
Clonidine (low dose)
NA agonist
↔
Atropine
muscarinic antagonist
↔ ↔ ↑↑
Atropine + clonidine (low dose)
muscarinic antagonist + NA agonist
↑↑
Clonidine (low dose) + atropine
NA agonist + muscarinic antagonist
↑↑
Carbachol
cholinergic agonist
↓↓ ↓↓
Carbachol + atropine
cholinergic agonist + muscarinic antagonist
↑↑ ↑↑
Atropine + carbachol
muscarinic antagonist + cholinergic agonist
↓↓
EDRO + atropine
AChE inhibitor + muscarinic antagonist
↑↓↓
EDRO + telenzepine
AChE inhibitor + M1 antagonist
↔
EDRO + telenzepine (high dose)
AChE inhibitor + M1 antagonist
↓↓
EDRO + methoctramine (METHOC)
AChE inhibitor + M2 antagonist
↑↓
EDRO + METHOC (high dose)
AChE inhibitor + M2 antagonist
↓↓
EDRO +
4-diphenylacetoxy-N-methylpiperidine metiodide
(4-DAMP)
AChE inhibitor + M3 antagonist
↓↓ ↑↑
MT-3
M4 antagonist
↔
Mecamylamine
nicotinic antagonist
↔
Mecamylamine + atropine
nicotinic antagonist + muscarinic antagonist
↔
Dihydro-β-erythrpidine
nicotinic antagonist
↑↑
↑↑, induced or enhanced locomotion; ↓↓, blocked locomotion; ↑, increased frequency; ↓, decreased amplitude; ↔, no effect.
(Miles et al., 2007). This effect is due to M2 receptor activation
at C-terminals on motoneurons (Evans, 1978; Witts et al., 2014).
Other neurons involved in controlling the CPG for locomo-
tion, currently unidentified, are implicated by the increase in
locomotor frequency produced by these drugs, consistent with
some tonic cholinergic suppression of CPG activity. Importantly,
M2 receptors, but not M1 or M3 receptors, reduce glutamate
release from primary afferents (Chen et al., 2014).
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M3 RECEPTORS ARE INVOLVED IN CHOLINERGIC ACTIVATION OF THE
SPINAL LOCOMOTOR CPG
The ability of the M3 receptor antagonist 4-DAMP (Table 1) to
initially reduce the frequency of locomotion induced by EDRO
and then to block it entirely at doses as low as 3 nM suggests
that the cells of the locomotor network that are activated by
the endogenous spinal action of ACh possess M3 receptors. The
distribution of M3 receptors in the spinal cord has not been
extensively described, although cells with M3 receptors have
been observed in laminae VII, VIII and X (Wilson et al., 2004).
Whether any of the cholinergic propriospinal neurons are among
those withM3 receptors is not known. There is evidence, however,
that cholinergic cells in the dorsal horn, lamina X, and the lat-
eral intermediate zone (laminae VI) are densely labeled with M2
receptors (Stewart and Maxwell, 2003). The distribution of neu-
rons in the ventral horn withM2 receptors has not been examined
in detail, except in the case of motoneurons (Wilson et al., 2004).
In summary, the in vitro data presented here establish that
well-coordinated locomotion can be produced in the isolated
neonatal rat spinal cord, and suggest that an endogenous pro-
priospinal cholinergic system could be a potential contributor to
the recovery of locomotion after SCI due to its ability to activate
the CPG for locomotion. The cholinergic propriospinal system
and glutamatergic propriospinal cells endogenous to the spinal
cord are among the remaining groups that might be responsible
for the ability of most animal species to regain locomotor func-
tion after complete SCI (Jordan and Schmidt, 2002; Rossignol
et al., 2002; Rossignol, 2006).
DOES THE CHOLINERGIC PROPRIOSPINAL SYSTEM CONTRIBUTE TO
NORMAL LOCOMOTION OR TO RECOVERY OF LOCOMOTION AFTER
SCI?
Our experiments using MLR-evoked locomotion in adult cats
with i.v. application of both nicotinic and muscarinic antagonists
(summarized in Table 1) suggest that there is very little contribu-
tion to normal locomotion by cholinergic systems, either at the
spinal or the brainstem level. This finding is not consistent with
the report by Garcia-Rill et al. (1987) who showed thatmuscarinic
receptor blockade by injecting antagonists directly into the cau-
dal brainstem could abolishMLR-evoked locomotion. Our results
show that even in cases where the stimulus site is optimum for
activation of the cholinergic cells in the vicinity of the MLR (i.e.,
pedunculopontine nucleus: cf. Rye et al., 1987), no decrement is
observed in the ability of MLR stimulation to evoke locomotion.
It would appear, therefore, that the frequently observed overlap of
cholinergic cells with the lowest threshold stimulation sites within
the MLR (Garcia-Rill et al., 1987; Garcia-Rill and Skinner, 1988)
is coincidental. Destruction of cholinergic cells in the dorsolateral
tegmentum-cholinergic cell area of cats (in the region corre-
sponding to the MLR) does not abolish the locomotor capacity of
the animal once recovery from the surgery is complete (Webster
and Jones, 1988). We conclude that the cholinergic contribution
to the induction of locomotion is not obligatory in mammals.
The absence of effects at the spinal level is consistent with the
failure of cholinergic antagonists to alter motoneuron activity in
cases where the activity is not produced by cholinergic activation.
The possibility that these results differ from those with intrathecal
drug application because of a reduced ability of atropine and/or
mecamylamine to enter the spinal cord in sufficient concentra-
tions to alter locomotion was discussed in the Methods section
of this paper, where we pointed out that the doses of these drugs
chosen were equivalent to those used previously to effectively alter
CNS effects. Clearly these drugs cross the blood-brain barrier in
sufficient quantities to produce effects on CNS processes.
In experiments on spinal cats we found that ACh, or EDRO
or carbachol, could not initiate locomotion soon after spinaliza-
tion (Table 1) but rather induced an increased tonic excitability so
that upon exteroceptive stimulation sustained contractions could
be evoked but no locomotion. This may have been due to an exci-
tatory effect on motoneurons. Our experiments with i.t. applica-
tions of carbachol in chronic spinal rats confirmed that carbachol
dramatically interferes with spinal stepping, and this effect is
reversed by atropine. To our surprise, atropine could improve
the spontaneous emerging locomotor pattern in the second post-
spinal week in spinal cats. We also found a synergy between
clonidine and atropine at this stage after SCI, so that a small dose
of clonidine which normally does not trigger locomotion could
now evoke a clear locomotor pattern. Dihydro-β-erythroidine, a
nicotinic antagonist, was also capable of facilitating locomotion
in chronic spinal cat, suggesting both muscarinic and nicotinic
control of the cholinergic propriospinal system.
This work suggests that in early days after spinalization, there is
a hyper-cholinergic state of the cord that interferes with the early
production of rhythmic activity. It indeed appears that adding
ACh stimulation just further disrupts the ability to walk. This is
consistent with observations using high dose intrathecal choliner-
gic agonist applications in intact rats (Yaksh et al., 1985; Gillberg
et al., 1990). The increased excitability might be attributable to a
direct action of cholinergic agonists on motoneurons, which can
be excited by ACh acting at M2 receptors (Witts et al., 2014). This
is consistent with our finding in vitro that motoneuron activity
during fictive locomotion is reduced by activation of cholinergic
M2 receptors. In addition to powerful suppression of cutaneous
afferent input, possibly via M2 receptors (Chen et al., 2014), the
cholinergic system appears to reorganize after SCI so that there
is an increased cholinergic suppression of CPG activation. This
would explain the absence of a locomotor facilitation by atropine
early after SCI while facilitating afferent input, and the efficacy of
clonidine to elicit locomotion at this stage. We interpret the fact
that clonidine and atropine have a synergistic effect at very low
doses at this stage as evidence that some means of activating the
CPG is required at this stage, but a few weeks after SCI develop-
ment of cholinergic control of some portion of the CPG allows
atropine to elicit locomotor activity without the need for another
means to facilitate CPG activity.
An important finding from these studies is the contrast
between the locomotor promoting action of cholinergic activa-
tion in the neonatal preparation and the reversal of this effect to
one that suppresses locomotion in the adult. There is no obvious
explanation for this, except to speculate that there may be features
of the cholinergic control that are present in the adult but absence
in the neonate, and vice versa. These might include differential
effects of descending pathways on the cholinergic propriospinal
system, or the later development of tonic control of afferent input.
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There is evidence that the cholinergic terminals of the dorsal horn
do not appear until sometime in the post-natal period (Phelps
et al., 1984), so their influence would not be exerted in neonatal
preparations.
Control of afferent input in adult animals is a mecha-
nism revealed by our results with injections of atropine. ACh
exerts both muscarinic and nicotinic control over sensory inputs
(Gillberg et al., 1990; Zhuo and Gebhart, 1991; Li et al., 2002;
Zhang et al., 2007; Chen et al., 2010, 2014; Hochman et al., 2010)
and it is possible that early on after spinalization a powerful
inhibition is exerted on afferent pathways that can be reversed
by cholinergic antagonists. It is known that after spinalization,
cats and rats depend much more on sensory inputs, having lost
all descending inputs, particularly relying on cutaneous afferents
from the foot (Bouyer and Rossignol, 2003b; Sławin´ska et al.,
2012). Our results showing atropine effects on the recovery of
locomotion and atropine enhancement of cutaneous input from
the SP nerve suggest that such a mechanism underlies these
results. This is also consistent with the differences between in vitro
locomotion, which is without cutaneous input from load recep-
tors on the foot pad, and the effects of the cholinergic agonists and
antagonists during treadmill stepping in spinal cats. Such cuta-
neous input is an absolute requirement for locomotion in spinal
cats (Bouyer and Rossignol, 2003b).
The possible role of ACh in the control of afferents that influ-
ence locomotion has not been investigated, although there is
evidence for cholinergic presynaptic inhibition (Ribeiro-Da-Silva
and Cuello, 1990; Hochman et al., 2010), including control of
non-nociceptive cutaneous afferents. Consistent with this, M2
receptors are found on primary afferent fibers, and they are elim-
inated with dorsal rhizotomy (Li et al., 2002). It is also clear that
there is postsynaptic control of sensory transmission by cholin-
ergic neurons of the dorsal horn. For example, there is evidence
for nicotinic modulation of GABAergic control of sensory input
(Genzen andMcGehee, 2005). The relative contributions of nico-
tinic and muscarinic receptors to the control of the sensory input
necessary for enhancement of locomotion by cholinergic antag-
onists in our study is unknown, but it is clear that both types
of receptors are involved in the control of sensory input to the
spinal cord.
IS THE CHOLINERGIC PROPRIOSPINAL SYSTEMMODIFIED AFTER SCI?
Chartlon et al. (1981) and Faden et al. (1986) found that mus-
carinic cholinergic receptor binding is reduced after spinal cord
transection. A dramatic decrease in cholinergic boutons on tail
motoneurons was observed after sacral SCI (Kitzman, 2006).
Skup et al. (2012) showed VAChT + boutons on TA MNs
increased slightly after SCI and locomotor training, while VAChT
boutons decreased dramatically on Sol MNs after spinaliza-
tion, and this was partly restored with training. Kapitza et al.
(2012) observed a progressive decrease in cholinergic input onto
motoneuron soma, and shrinkage of cholinergic interneuron cell
bodies located around the central canal after SCI. They suggested
that “. . . reduced cholinergic input on motoneurons is assumed
to result in the rapid exhaustion of the central drive required
for the performance of locomotor movements in animals and
humans. . ..” These observations predict that the effect of SCI
should be a reduced excitability of motoneurons and other targets
of the cholinergic propriospinal cells. Our results directly contra-
dict these predictions, and show evidence for a hyper-cholinergic
state after SCI. They suggest the use of cholinergic antagonists as
a potential treatment of recovery of function after SCI. They fur-
ther suggest that the suppression of afferent input to the spinal
cord by ACh via both muscarinic and nicotinic receptors is the
key to understanding the role of ACh in motor control after SCI.
CONCLUSIONS
Our results show a potent cholinergic control of locomotor
activity emerges after spinal cord injury, but in contrast to expec-
tations, it was neither a decrease in motoneuron excitability, as
predicted by recent findings, nor a recruitment of cholinergic
propriospinal cells to account for stepping in spinal animals.
Instead, a hyper-cholinergic state that supressed locomotor activ-
ity emerged, and this could be reduced with cholinergic antago-
nists to facilitate locomotion. Figure 14 summarizes the choliner-
gic neurons that might account for our results. V0c (Pitx2) and
commissural cholinergic neurons (CIN) contact motoneurons
directly and increase their excitability, while unknown choliner-
gic interneurons, likely from the partition cell and central canal
cluster cell groups, project to CPG neurons and account for
the cholinergic locomotor rhythm control (LRC). Dorsal horn
cholinergic interneurons known to inhibit cutaneous afferent
input and produce analgesia, either by presynaptic inhibition or
by controlling other interneurons (not shown) that are respon-
sible for afferent input control (AIC) are also illustrated. The
AIC cholinergic cells are the most likely ones to account for
the ability of cholinergic antagonists to facilitate locomotion. We
believe such a population of AIC cholinergic neurons must ton-
ically inhibit afferent feedback necessary for locomotor activity
in spinal animals. It is likely that controlling the activity of these
neurons will provide a new opportunity for restoring locomotion
after injury.
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